1 / 7

Global Colorectal Cancer Drugs Market 2015 Trends, Demand, Growth & Forecast to 2019

Colorectal cancer refers to malignancies that originate in the rectum or the colon. It is also known as bowel cancer. Formation of adenocarcinomas is the most common feature of colorectal cancer. The cancer starts as a polyp in the inner wall of the colon or rectum. These polyps can be benign or malignant. Colorectal cancer is the third most common cancer in the US. Some of the risk factors that can cause colorectal cancer are lifestyle changes, old age, genetic disorders, family history, and inflammatory bowel disease. Some of the symptoms of colorectal cancer are blood in stool, decrease in appetite, constipation, weight loss, nausea, bloating, and pelvic pain. Colorectal cancer can be classified into four broad stages. Colorectal cancer can be treated using surgical, chemotherapeutic, biologic, and radiation therapies.<br><br>The global colorectal cancer drugs market to grow at a CAGR of 3.62% over the period 2014-2019.<br><br>Read more details at: http://www.bigmarketresearch.com/global-colorectal-cancer-drugs-2015-2019-market<br>

Bradon
Download Presentation

Global Colorectal Cancer Drugs Market 2015 Trends, Demand, Growth & Forecast to 2019

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Top 10 Diabetes Care Technologies, Devices and Therapeutics Markets - Growth, Global Share, Industry Overview, Analysis, Trends Opportunities and Forecast 2012 - 2020 Global Colorectal Cancer Drugs Market 2015-2019 Growth, Global Share, Industry Overview, Analysis, Trends Opportunities and Forecast

  2. Description Report Overview About Colorectal Cancer Colorectal cancer refers to malignancies that originate in the rectum or the colon. It is also known as bowel cancer. Formation of adenocarcinomas is the most common feature of colorectal cancer. The cancer starts as a polyp in the inner wall of the colon or rectum. These polyps can be benign or malignant. Colorectal cancer is the third most common cancer in the US. Some of the risk factors that can cause colorectal cancer are lifestyle changes, old age, genetic disorders, family history, and inflammatory bowel disease. Some of the symptoms of colorectal cancer are blood in stool, decrease in appetite, constipation, weight loss, nausea, bloating, and pelvic pain. Colorectal cancer can be classified into four broad stages. Colorectal cancer can be treated using surgical, chemotherapeutic, biologic, and radiation therapies. The global colorectal cancer drugs market to grow at a CAGR of 3.62% over the period 2014-2019. Read more details at: http://www.bigmarketresearch.com/global-colorectal-cancer-drugs-2015-2019-market

  3. Key Benefits Summery Covered in this Report Global Colorectal Cancer Drugs, report covers the present scenario and the growth prospects of the global colorectal cancer drugs market for the period 2015-2019. To calculate the market size, the report considers revenue generated from sales of various drugs used in the treatment of colorectal cancer. Based on the type of molecule, the market is grouped into two categories: • Biologics • Small molecules Based on the route of administration, the market is grouped into two categories: • Oral • Parenteral Global Colorectal Cancer Drugs, report also presents the vendor landscape and a corresponding detailed analysis of the top vendors as well as the competitive performances of their product portfolios in the market. In addition, it discusses the major drivers that influence the growth of the market.

  4. Key Audiences Key Regions • Americas • APAC • EMEA Key Vendors • Amgen • Bayer • Bristol-Myers Squibb • F. Hoffmann-La Roche • Merck Serono

  5. Table Of Contents Key Audiences Other Prominent Vendors • Accord Healthcare • Advenchen Laboratories • AeternaZentaris • AstraZeneca • Bavarian Nordic • Biothera • BoehringerIngelheim • Daiichi Sankyo • Debiopharm • Eisai • Eli Lilly • Immodulon Therapeutics • Mologen • Mylan • Nektar Therapeutics • Oncothyreon

  6. Table Of Contents Market Trends: Market Driver • Increase in population of patients • For a full, detailed list, view our report Market Challenge • Loss of patent exclusivity • For a full, detailed list, view our report Market Trend • Dominance of biologics • For a full, detailed list, view our report Enquire About Report:http://www.bigmarketresearch.com/report-enquiry/250645

  7. Get Full Information At: http://www.bigmarketresearch.com/global-colorectal-cancer-drugs-2015-2019-market

More Related